IRIS
PATRONE, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.383
Totale 19.383
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.383
Totale 19.383
Salva come PNG Salva come JPEG
Città #
Genova 15.082
Rapallo 2.204
Genoa 1.736
Vado Ligure 319
Bordighera 42
Totale 19.383
Salva come PNG Salva come JPEG
Nome #
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 176
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 175
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 175
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 172
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 169
Autophagy in blood cancers: biological role and therapeutic implications. 168
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 164
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 157
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 157
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. 155
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 153
APO866 activity in hematologic malignancies: a preclinical in vitro study. 150
Anticancer vaccination strategies. 150
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 149
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 147
Ras-induced resistance to lapatinib is overcome by MEK inhibition 144
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 144
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 144
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 142
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 141
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 141
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 140
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 139
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 137
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 136
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 136
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 132
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 132
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 130
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 129
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 129
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 128
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 128
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 128
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 126
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 123
New insights into biology of chronic myeloid leukemia: implications in therapy. 122
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. 122
In vitro effects of synthetic chemotactic peptides on neutrophil function. 121
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 120
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. 120
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide and cisplatin (CEP) 119
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 119
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 119
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 118
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 118
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 117
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. 117
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 117
A simple acid-precipitation test for rapid screening of monoclonal gammopathies. 116
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 116
Stimulation of neutrophil locomotion by inosiplex. 115
The use of dendritic cells in cancer immunotherapy. 115
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 115
Neutrophil functions in acne conglobata. 114
Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. 114
The proteasome and its inhibitors in immune regulation and immune disorders. 113
Hyperimmunoglobulinemia E syndrome. 113
Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells. 113
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 113
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 111
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 111
Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. 110
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. 110
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 110
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 110
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. 110
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 109
Autologous peripheral blood stem cells (PBSC) in breast cancer. 109
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer 108
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 108
Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. 108
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 107
Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. 107
Neutrophil chemotaxis: physiology and pathology. 106
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 106
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 105
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 105
Evidence for a reversible functional state of neutrophil chemotactic deactivation. 103
Intracellular NAD+ depletion induces autophagic-death in Multiple Myeloma cells 103
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 102
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 102
Immunopathological studies on a case of Sweet's syndrome. 102
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. 102
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 102
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 102
Proteasome inhibitors: antitumor effects and beyond 102
Target cell lysis mediated by concanavalin A-triggered human neutrophils. 101
Extracellular cytolysis by leukaemic blast cells. 100
Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation. 100
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 100
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 99
Defective neutrophil chemotaxis and bactericidal power in a child with hyperimmunoglobulinemia E. 98
Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation. 98
[Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method]. 97
Neutropenia and impaired neutrophil function in glycogenosis type Ib. 97
Repeated skin infections as a manifestation of lupus erythematosus. 96
Normal polymorphonuclear neutrophil function in a case of glycogen storage disease type Ib. 95
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. 95
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 95
Totale 12.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.259
article - articoli 48.356
book - libri 0
conference - conferenze 287
curatela - curatele 0
other - altro 0
patent - brevetti 39
selected - selezionate 0
volume - volumi 577
Totale 98.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.847 0 0 238 316 468 511 930 299 389 904 585 207
2020/20211.243 109 100 71 77 80 130 76 106 130 116 145 103
2021/20222.402 57 182 172 256 176 144 128 536 78 243 109 321
2022/20232.651 270 195 18 290 437 490 12 199 462 12 241 25
2023/20241.256 44 159 23 148 99 268 43 140 54 21 64 193
2024/2025395 109 270 16 0 0 0 0 0 0 0 0 0
Totale 19.483